Diagnosis and evaluation of prognosis of myelofibrosis: a British Society for Haematology Guideline
This document represents an update of the British Society for Haematology (BSH) guideline on myelofibrosis (MF) first published in 2012 and updated in 2015.1 This guideline aims to provide healthcare professionals with clear guidance on the diagnosis and prognostic evaluation of primary myelofibrosi...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Other Authors: | |
Format: | Journal article |
Language: | English |
Published: |
Wiley
2023
|
_version_ | 1826315133443375104 |
---|---|
author | McLornan, DP Godfrey, AL Green, A Frewin, R Arami, S Brady, J Butt, NM Cargo, C Ewing, J Francis, S Garg, M Harrison, C Innes, A Khan, A Knapper, S Lambert, J Mead, A McGregor, A Neelakantan, P Psaila, B Somervaille, TCP Woodley, C Nangalia, J Cross, NCP McMullin, MF |
author2 | BSH Committee |
author_facet | BSH Committee McLornan, DP Godfrey, AL Green, A Frewin, R Arami, S Brady, J Butt, NM Cargo, C Ewing, J Francis, S Garg, M Harrison, C Innes, A Khan, A Knapper, S Lambert, J Mead, A McGregor, A Neelakantan, P Psaila, B Somervaille, TCP Woodley, C Nangalia, J Cross, NCP McMullin, MF |
author_sort | McLornan, DP |
collection | OXFORD |
description | This document represents an update of the British Society for Haematology (BSH) guideline on myelofibrosis (MF) first published in 2012 and updated in 2015.1 This guideline aims to provide healthcare professionals with clear guidance on the diagnosis and prognostic evaluation of primary myelofibrosis (PMF), as well as post-polycythaemia vera myelofibrosis (post-PV MF) and post-essential thrombocythaemia myelofibrosis (post-ET MF). A section on prefibrotic MF is also included. A separate BSH Guideline covers the management of MF and is published alongside this guideline. |
first_indexed | 2024-03-07T08:17:15Z |
format | Journal article |
id | oxford-uuid:74d5f80a-f0e0-44c9-9d1d-6d33c8e5e25f |
institution | University of Oxford |
language | English |
last_indexed | 2024-12-09T03:20:21Z |
publishDate | 2023 |
publisher | Wiley |
record_format | dspace |
spelling | oxford-uuid:74d5f80a-f0e0-44c9-9d1d-6d33c8e5e25f2024-11-07T11:14:37ZDiagnosis and evaluation of prognosis of myelofibrosis: a British Society for Haematology GuidelineJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:74d5f80a-f0e0-44c9-9d1d-6d33c8e5e25fEnglishSymplectic ElementsWiley2023McLornan, DPGodfrey, ALGreen, AFrewin, RArami, SBrady, JButt, NMCargo, CEwing, JFrancis, SGarg, MHarrison, CInnes, AKhan, AKnapper, SLambert, JMead, AMcGregor, ANeelakantan, PPsaila, BSomervaille, TCPWoodley, CNangalia, JCross, NCPMcMullin, MFBSH CommitteeThis document represents an update of the British Society for Haematology (BSH) guideline on myelofibrosis (MF) first published in 2012 and updated in 2015.1 This guideline aims to provide healthcare professionals with clear guidance on the diagnosis and prognostic evaluation of primary myelofibrosis (PMF), as well as post-polycythaemia vera myelofibrosis (post-PV MF) and post-essential thrombocythaemia myelofibrosis (post-ET MF). A section on prefibrotic MF is also included. A separate BSH Guideline covers the management of MF and is published alongside this guideline. |
spellingShingle | McLornan, DP Godfrey, AL Green, A Frewin, R Arami, S Brady, J Butt, NM Cargo, C Ewing, J Francis, S Garg, M Harrison, C Innes, A Khan, A Knapper, S Lambert, J Mead, A McGregor, A Neelakantan, P Psaila, B Somervaille, TCP Woodley, C Nangalia, J Cross, NCP McMullin, MF Diagnosis and evaluation of prognosis of myelofibrosis: a British Society for Haematology Guideline |
title | Diagnosis and evaluation of prognosis of myelofibrosis: a British Society for Haematology Guideline |
title_full | Diagnosis and evaluation of prognosis of myelofibrosis: a British Society for Haematology Guideline |
title_fullStr | Diagnosis and evaluation of prognosis of myelofibrosis: a British Society for Haematology Guideline |
title_full_unstemmed | Diagnosis and evaluation of prognosis of myelofibrosis: a British Society for Haematology Guideline |
title_short | Diagnosis and evaluation of prognosis of myelofibrosis: a British Society for Haematology Guideline |
title_sort | diagnosis and evaluation of prognosis of myelofibrosis a british society for haematology guideline |
work_keys_str_mv | AT mclornandp diagnosisandevaluationofprognosisofmyelofibrosisabritishsocietyforhaematologyguideline AT godfreyal diagnosisandevaluationofprognosisofmyelofibrosisabritishsocietyforhaematologyguideline AT greena diagnosisandevaluationofprognosisofmyelofibrosisabritishsocietyforhaematologyguideline AT frewinr diagnosisandevaluationofprognosisofmyelofibrosisabritishsocietyforhaematologyguideline AT aramis diagnosisandevaluationofprognosisofmyelofibrosisabritishsocietyforhaematologyguideline AT bradyj diagnosisandevaluationofprognosisofmyelofibrosisabritishsocietyforhaematologyguideline AT buttnm diagnosisandevaluationofprognosisofmyelofibrosisabritishsocietyforhaematologyguideline AT cargoc diagnosisandevaluationofprognosisofmyelofibrosisabritishsocietyforhaematologyguideline AT ewingj diagnosisandevaluationofprognosisofmyelofibrosisabritishsocietyforhaematologyguideline AT franciss diagnosisandevaluationofprognosisofmyelofibrosisabritishsocietyforhaematologyguideline AT gargm diagnosisandevaluationofprognosisofmyelofibrosisabritishsocietyforhaematologyguideline AT harrisonc diagnosisandevaluationofprognosisofmyelofibrosisabritishsocietyforhaematologyguideline AT innesa diagnosisandevaluationofprognosisofmyelofibrosisabritishsocietyforhaematologyguideline AT khana diagnosisandevaluationofprognosisofmyelofibrosisabritishsocietyforhaematologyguideline AT knappers diagnosisandevaluationofprognosisofmyelofibrosisabritishsocietyforhaematologyguideline AT lambertj diagnosisandevaluationofprognosisofmyelofibrosisabritishsocietyforhaematologyguideline AT meada diagnosisandevaluationofprognosisofmyelofibrosisabritishsocietyforhaematologyguideline AT mcgregora diagnosisandevaluationofprognosisofmyelofibrosisabritishsocietyforhaematologyguideline AT neelakantanp diagnosisandevaluationofprognosisofmyelofibrosisabritishsocietyforhaematologyguideline AT psailab diagnosisandevaluationofprognosisofmyelofibrosisabritishsocietyforhaematologyguideline AT somervailletcp diagnosisandevaluationofprognosisofmyelofibrosisabritishsocietyforhaematologyguideline AT woodleyc diagnosisandevaluationofprognosisofmyelofibrosisabritishsocietyforhaematologyguideline AT nangaliaj diagnosisandevaluationofprognosisofmyelofibrosisabritishsocietyforhaematologyguideline AT crossncp diagnosisandevaluationofprognosisofmyelofibrosisabritishsocietyforhaematologyguideline AT mcmullinmf diagnosisandevaluationofprognosisofmyelofibrosisabritishsocietyforhaematologyguideline |